QbD Clinical Holding
0753.439.481 · rovalta.com · 26/09/2026
QbD Clinical Holding
Company — Normal situation.
Financial year 2023 · Closed on 30/09/2023
Overview
Identity
Source · BCE/KBOQbD Clinical Holding is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0753.439.481
- Legal form
- Private limited company
- Contributed capital
- 300 000,00 €
- Latest accounts
- 30/09/2023
Financials
Source · NBB, 3 filingsTrend over 3 financial years
| 2023 | 2022 | 2021 | |||
|---|---|---|---|---|---|
| Income statement | |||||
| Gross margin | -49,7 k € | -122% | 224,7 k € | +72.0% | 130,7 k € |
| EBITDA | -49,8 k € | -122% | 224,4 k € | +72.4% | 130,1 k € |
| Operating result | -49,8 k € | -122% | 224,4 k € | +72.4% | 130,1 k € |
| Net result | 7,1 M € | +938% | 687,8 k € | +16.3% | 591,4 k € |
| Balance sheet | |||||
| Equity | 8,7 M € | +452% | 1,6 M € | +77.2% | 891,4 k € |
| Total assets | 11,3 M € | +169% | 4,2 M € | +5.7% | 4 M € |
| Cash | 139,7 k € | -52.7% | 295,3 k € | +151% | 117,6 k € |
| Debts | 2,6 M € | -1.6% | 2,6 M € | -15.1% | 3,1 M € |
Board of directors
Source · NBB, accounts to 30/09/20234 active · 4 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2023 | 01/01/2022 | 01/09/2020 |
| Closing of the financial year | 30/09/2023 | 31/12/2022 | 31/12/2021 |
| Length of the financial year | 9 months | 12 months | 16 months |
| Filing date | 24/04/2024 | 28/07/2023 | 29/07/2022 |
| General meeting | 31/03/2024 | 30/06/2023 | 30/06/2022 |
| Currency of the financial year | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 3 filingsValuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/20234 active · 4 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution16/01/2024RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ...
- Restructuring26/09/2023RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...) - DIVERSEN
- Mandates25/05/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - BENAMING - ONTSLAGEN - BENOEMINGEN
- Registered office10/11/2022MAATSCHAPPELIJKE ZETEL
- Mandates17/06/2022ONTSLAGEN - BENOEMINGEN
- Other01/09/2020RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2023Annual accounts 20237,1 M €↑
- 2022Annual accounts 2022687,8 k €↑
- 2022Name changeQbD Clinical Holding
- 2021Annual accounts 2021591,4 k €
- 2021Name changeQBD Trium Holding